C4 Therapeutics Inc
For the period ended Oct 31, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 31, 2024 · Filed Oct 31, 2024
Use the contents to explore the available documents and sections.
CCCC$3.10+5.1%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands)
(in thousands)
| (unaudited) | (audited) | |
|---|---|---|
| September 30, 2024 | December 31, 2023 | |
| Cash, cash equivalents and marketable securities | $284,400 | $281,689 |
| Total assets | 376,060 | 376,451 |
| Deferred revenue | 49,417 | 37,285 |
| Total stockholders' equity | 242,656 | 246,114 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.